XML 34 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Information (Tables)
6 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Schedule of segment performance measures

Six Months Ended December 31, 2015 and 2014:

 

    Human
Health
    Pharmaceutical
Ingredients
    Performance
Chemicals
    Unallocated
Corporate
    Consolidated
Totals
 
2015                                        
Net sales   $ 116,526     $ 72,655     $ 75,993     $ -     $ 265,174  
Gross profit     42,047       12,222       16,180       -       70,449  
Income (loss) before income taxes     21,297       3,781       6,804       (3,806 )     28,076  
                                         
2014                                        
Net sales   $ 104,503     $ 70,556     $ 79,509     $ -     $ 254,568  
Gross profit     30,872       13,076       13,722       -       57,670  
Income (loss) before income taxes     12,429       3,860       4,820       (2,979 )     18,130  
                                         

 

 

Three Months Ended December 31, 2015 and 2014:

 

    Human
Health
    Pharmaceutical
Ingredients
    Performance
Chemicals
    Unallocated
Corporate
    Consolidated
Totals
 
2015                                        
Net sales   $ 59,045     $ 34,295     $ 38,334     $ -     $ 131,674  
Gross profit     21,738       6,108       8,022       -       35,868  
Income (loss) before income taxes     10,794       1,682       3,260       (2,643 )     13,093  
                                         
2014                                        
Net sales   $ 55,424     $ 32,579     $ 35,762     $ -     $ 123,765  
Gross profit     16,331       6,926       6,762       -       30,019  
Income (loss) before income taxes     6,972       2,327       2,896       (1,710 )     10,485